Puma Biotech, Which Had Weak Demand For A Secondary Offering, Is Also Part Of The SEC Tick Size Pilot Program
October 21, 2016 at 12:34 PM EDT
Puma Biotechnology Inc(NYSE:PBYI) has had one of its most volatile weeks in recent memory thanks to weak demand for a ...